Conference item
Intravenous immune globulin in chronic lymphocytic leukaemia.
- Abstract:
-
The most common complication of chronic lymphocytic leukaemia (CLL) is infection, which occurs mainly in advanced stages of disease or in those patients with hypogammaglobulinaemia. Intravenous immune globulin (IVIG) has been shown to be a useful prophylactic therapy against infections in such patients. A randomized, double-blind study on 36 patients receiving either 500 mg/kg or 250 mg/kg IVIG every 4 weeks was undertaken to determine the dose regimen required. There was no significant diffe...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Volume:
- 97 Suppl 1
- Pages:
- 17-20
- Host title:
- Clinical and experimental immunology
- Publication date:
- 1994-07-01
- Event location:
- ENGLAND
- EISSN:
-
1365-2249
- ISSN:
-
0009-9104
- Source identifiers:
-
66982
Item Description
- Keywords:
- Pubs id:
-
pubs:66982
- UUID:
-
uuid:41cebeee-daf5-4943-965f-f27bd9c74a63
- Local pid:
- pubs:66982
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 1994
If you are the owner of this record, you can report an update to it here: Report update to this record